DCM
DAFNA Capital Management Portfolio holdings
AUM
$362M
This Quarter Return
+13.83%
1 Year Return
-0.48%
3 Year Return
+117.01%
5 Year Return
+181.93%
10 Year Return
+1,483.26%
AUM
$421M
AUM Growth
+$421M
(+25%)
Cap. Flow
+$56.4M
Cap. Flow
% of AUM
13.37%
Top 10 Holdings %
Top 10 Hldgs %
50.23%
Holding
96
New
22
Increased
24
Reduced
22
Closed
7
Top Buys
| 1 |
Nurix Therapeutics
NRIX
|
$9.52M |
| 2 |
MORF
Morphic Holding, Inc. Common Stock
MORF
|
$7.59M |
| 3 |
Revolution Medicines
RVMD
|
$5.91M |
| 4 |
Protalix BioTherapeutics
PLX
|
$5.37M |
| 5 |
Adicet Bio
ACET
|
$4.02M |
Top Sells
| 1 |
Cassava Sciences
SAVA
|
$3.07M |
| 2 |
CNST
Constellation Pharmaceuticals, Inc.
CNST
|
$2.9M |
| 3 |
AGTC
Applied Genetic Technologies Corporation
AGTC
|
$2.4M |
| 4 |
Neuronetics
STIM
|
$2.35M |
| 5 |
Neurocrine Biosciences
NBIX
|
$1.8M |
Sector Composition
| 1 | Healthcare | 90.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
LMNX
26
DELISTED
Luminex Corp
LMNX
| $4.92M | 1.17% |
154,091
| – | – |
|
27
Accuray
ARAY
$165M
| $4.66M | 1.11% |
941,800
-32,600
| -3% | -$161K |
|
|
HOOK
28
DELISTED
HOOKIPA Pharma
HOOK
| $4.62M | 1.1% |
34,346
+9,346
| +37% | +$1.26M |
|
|
MREO
29
Mereo BioPharma
MREO
$275M
| $4.21M | 1% |
1,249,648
+581,500
| +87% | +$1.96M |
|
|
TBIO
30
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $3.72M | 0.88% |
225,393
| – | – |
|
|
RDHL
31
Redhill Biopharma
RDHL
$2.94M
| $3.34M | 0.79% |
+456
| New | +$3.34M |
|
32
Merus
MRUS
$5.04B
| $3.3M | 0.78% |
+157,841
| New | +$3.3M |
|
|
33
Neuronetics
STIM
$208M
| $3.14M | 0.74% |
253,717
-190,000
| -43% | -$2.35M |
|
34
Ascendis Pharma
ASND
$12.1B
| $3M | 0.71% |
23,237
| – | – |
|
|
PRDS
35
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
| $2.99M | 0.71% |
+300,000
| New | +$2.99M |
|
36
Venus Concept
VERO
$4.07M
| $2.89M | 0.69% |
7,457
-1,634
| -18% | -$633K |
|
37
Viking Therapeutics
VKTX
$3.02B
| $2.83M | 0.67% |
447,400
-8,500
| -2% | -$53.8K |
|
|
HARP
38
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $2.65M | 0.63% |
12,666
+4,154
| +49% | +$869K |
|
39
Alector
ALEC
$282M
| $2.57M | 0.61% |
127,500
| – | – |
|
40
89bio
ETNB
$1.37B
| $2.5M | 0.59% |
105,478
| – | – |
|
|
NTUS
41
DELISTED
Natus Medical Inc
NTUS
| $2.45M | 0.58% |
95,653
+10,078
| +12% | +$258K |
|
42
InflaRx
IFRX
$117M
| $2.34M | 0.56% |
+600,000
| New | +$2.34M |
|
|
ASLN
43
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
| $2.27M | 0.54% |
+16,938
| New | +$2.27M |
|
44
MEI Pharma
MEIP
$149M
| $2.22M | 0.53% |
32,300
-2,250
| -7% | -$154K |
|
|
AGTC
45
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $2.18M | 0.52% |
430,111
-473,318
| -52% | -$2.4M |
|
46
Acadia Pharmaceuticals
ACAD
$4.34B
| $2.14M | 0.51% |
+83,000
| New | +$2.14M |
|
|
PHAS
47
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
| $2.09M | 0.5% |
603,042
+282,500
| +88% | +$978K |
|
48
Disc Medicine
IRON
$2.14B
| $2.03M | 0.48% |
+5,000
| New | +$2.03M |
|
49
Mersana Therapeutics
MRSN
$34.8M
| $2.01M | 0.48% |
4,971
+3,000
| +152% | +$1.21M |
|
50
Cogent Biosciences
COGT
$1.83B
| $1.96M | 0.47% |
+223,554
| New | +$1.96M |
|